MSF Science Portal
My saved items
Conference Material > Video (talk)
24-week regimens for treatment of rifampicin-resistant tuberculosis: four-arm randomised trial
Berry C,
Motta I,
Kazounis E,
Fielding K,
Dodd M,
Nyang'wa BT,
Moodliar R
Share
Linked Items
Share
Video
Countries
Belarus
South Africa
Uzbekistan
Subject Area
antibiotic resistance
tuberculosis
antimicrobial resistance
Collections
TB-PRACTECAL Trial—Evidence for a shorter, safer, more effective treatment for drug-resistant tuberculosis
DOI
10.57740/atfr-ws57
Published Date
07-Jun-2022
Languages
English
Conference
MSF Scientific Days International 2022
Linked Items
24-week regimens for treatment of rifampicin-resistant tuberculosis: four-arm randomised trial
11-May-2022
24-week regimens for treatment of rifampicin-resistant tuberculosis: four-arm randomised trial
11-May-2022
